Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. (2022)

First Author: Hudert CA
Attributed to:  The validation of biomarkers of metabolic efficacy in infant nutrition funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hep4.1955

PubMed Identifier: 35411667

Publication URI: http://europepmc.org/abstract/MED/35411667

Type: Journal Article/Review

Volume: 6

Parent Publication: Hepatology communications

Issue: 8

ISSN: 2471-254X